ALKS ALKERMES PLC Disposals and divestitures 8-K Filing 2023 - Asset Sale Alkermes plc entered into an asset purchase agreement with Novo Nordisk to sell its development and manufacturing facility in Ireland for $92.5 million, with the closing expected in mid-2024.Get access to all SEC 8-K filings of the ALKERMES PLC